We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase (NECT-FIELD)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00906880
First Posted: May 21, 2009
Last Update Posted: May 31, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Ministry of Public Health, Democratic Republic of the Congo
Swiss Tropical & Public Health Institute
Information provided by (Responsible Party):
Drugs for Neglected Diseases
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Publications:

To Top